Private company

GB SCIENCES INC

GB SCIENCES INC is an American crude petroleum and natural gas company based in Las Vegas.1

Last updated Oct 20, 2026.

Overview

$0Revenue, fiscal 20242
-$1.4MNet income, fiscal 20242
  • IndustryCrude Petroleum & Natural Gas1
  • HeadquartersLas Vegas, Nevada1
  • Incorporated inNV3
  • Business address6450 Cameron Street #110A, Las Vegas, Nv 891183
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Revenue456782$0 in 2024
0$1.0M$2.0M$3.0M$4.0M2017: $0$020172018: $2.5M$2.5M20182019: $3.5M$3.5M2019+38%2020: $3.1M$3.1M2020−10%2021: $0$020212022: $0$020222023: $0$020232024: $0$02024
Gross profit956782$0 in 2024
-$1.0M0$1.0M$2.0M2017: $0$020172018: $1.7M$1.7M20182019: $208.5K$208.5K2019−88%2020: -$881.5K-$881.5K20202021: $0$02021−100%2022: $0$020222023: $0$020232024: $0$02024
Operating income95610782-$1.4M in 2024−84% since 2017
-$20.0M-$15.0M-$10.0M-$5.0M02017: -$8.9M-$8.9M20172018: -$17.8M-$17.8M2018+100%2019: -$13.2M-$13.2M2019−26%2020: -$5.7M-$5.7M2020−56%2021: -$2.0M-$2.0M2021−65%2022: -$1.9M-$1.9M2022−7%2023: -$1.7M-$1.7M2023−11%2024: -$1.4M-$1.4M2024−15%
Net income95610782-$1.4M in 2024−86% since 2017
-$30.0M-$20.0M-$10.0M02017: -$9.9M-$9.9M20172018: -$23.0M-$23.0M2018+132%2019: -$23.7M-$23.7M2019+3%2020: -$12.4M-$12.4M2020−48%2021: -$3.7M-$3.7M2021−70%2022: -$530.9K-$530.9K2022−86%2023: -$4.1M-$4.1M2023+677%2024: -$1.4M-$1.4M2024−67%
Fiscal year20172018201920202021202220232024
Revenue$04$2.5M5$3.5M6$3.1M6$07$08$02$02
Cost of revenue$09$782.7K5$3.2M6$4.0M6$07$08$02$02
Gross profit$09$1.7M5$208.5K6-$881.5K6$07$08$02$02
Research and development$458.8K6$1.5M10$352.3K7$821.3K8$490.3K2$261.6K2
Operating expenses$1.7M2$1.4M2
Operating income-$8.9M9-$17.8M5-$13.2M6-$5.7M10-$2.0M7-$1.9M8-$1.7M2-$1.4M2
Interest$901.1K9$5.2M5$4.9M6$1.1M10$1.3M7$474.8K8$178.7K8
Income before tax-$146.5K8-$4.1M2-$1.4M2
Income tax$09$05$526.1K6$86.8K6$07$08$02$02
Net income-$9.9M9-$23.0M5-$23.7M6-$12.4M10-$3.7M7-$530.9K8-$4.1M2-$1.4M2
Earnings per share-$0.017$0.008-$0.012$0.002
Earnings per share (diluted)$0.0114$0.0114
Shares (weighted, basic)317.4M shares14316.9M shares14357.7M shares2396.7M shares2
Shares (weighted, diluted)342.3M shares14343.5M shares14

Compare GB SCIENCES INC with another company

What it owns

What GB SCIENCES INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$12.0K2 Mar 31, 2024$109.9K2 Mar 31, 2023−89.1%
Marketable securities, current$02 Mar 31, 2024$08 Mar 31, 2023

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, net$02 Mar 31, 2024$42.8K2 Mar 31, 2023−100.0%

Leadership

Who has led GB SCIENCES INC, and when. Pick a name to see everywhere that person has worked.

20202025
Board members and other officers (3)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorAndrea Small-Howard named Jun 3, 2022 to Aug 2, 202318
  • Executive OfficerZach Swarts named Jun 3, 202219
  • DirectorEdmond DeFrank named Jun 3, 2022 to Aug 2, 202318

Former names

  • Growblox Sciences, Inc.Jun 4, 2014 to May 12, 20173
  • Signature Exploration & Production Corp.Jun 2, 2008 to May 9, 20143
  • Diabetic Treatment Centers of America, Inc.Aug 16, 2004 to Mar 6, 20083
  • FLAGSTICK VENTURES INCFeb 12, 2002 to Aug 5, 20043

Timeline

  1. Oct 15, 20248-K Entered a material agreement20
  2. Jul 16, 20248-K Executive or director change21
  3. Jun 21, 20248-K Other events22
  4. Sep 8, 20238-K Unregistered sale of shares; Executive or director change23
  5. Apr 14, 20238-K Executive or director change24
  6. Mar 10, 20238-K Shareholder vote25
  7. Aug 30, 20228-K Unregistered sale of shares26
  8. Mar 16, 20228-K Other events27
  9. Jan 6, 20228-K Completed an acquisition or sale28
  10. Jul 27, 2018New chief executive John C. Poss becomes CEO15
  11. Jun 16, 2017New chief executive Craig Ellins becomes CEO16

Filings

41 filings to the SEC since October 2021: 3 annual reports, 11 quarterly reports, 9 major events, 2 private raises, 16 other. The latest 20:

  1. Nov 19, 2025NT 10-Q EDGAR
  2. Oct 17, 2025NT 10-Q EDGAR
  3. Oct 17, 2025NT 10-K EDGAR
  4. Aug 12, 202510-Q EDGAR
  5. Feb 12, 2025NT 10-Q EDGAR
  6. Nov 27, 202410-Q EDGAR
  7. Nov 27, 202410-Q EDGAR
  8. Nov 14, 2024NT 10-Q EDGAR
  9. Oct 15, 20248-K EDGAR
  10. Aug 30, 202410-K EDGAR
  11. Aug 14, 2024NT 10-Q EDGAR
  12. Jul 16, 20248-K EDGAR
  13. Jul 1, 2024NT 10-K EDGAR
  14. Jun 21, 20248-K EDGAR
  15. Feb 12, 202410-Q EDGAR
  16. Nov 20, 202310-Q EDGAR
  17. Nov 14, 2023NT 10-Q EDGAR
  18. Oct 10, 2023424B3 EDGAR
  19. Sep 8, 20238-K GB SCIENCES, INC. - FORM 8-K SEC FILING EDGAR
  20. Aug 14, 202310-Q EDGAR

The 41 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jun 30, 2023Raised $75,000 in a private offering of debt Form D: $1 million offered in all Form D
  2. May 20, 2022Raised $25,000 in a private offering of equity Form D: $565,000 offered in all Form D

SEC filer profile

How GB SCIENCES INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARGB SCIENCES INC1
  • CIK0001165320
  • Employer ID (EIN)59-37331331
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inNevada1
  • Fiscal year endsMarch 311
  • Industry code (SIC)1311 Crude Petroleum & Natural Gas1
  • SEC reviewing officeOffice of Energy & Transportation, Division of Corporation Finance1
  • Business address6450 Cameron Street #110A, Las Vegas, NV 891181
  • Phone(844) 843-25691
  • Shares outstanding407,071,028 as of Aug 11, 202513
  • Public float$4.0M as of Sep 30, 20232
  • On EDGAR sinceFeb 12, 20021
  • Filings394 in all: 8-K (109), 10-Q (51), NT 10-Q (26), 10QSB (18), NT 10-K (18), 10-K (17), 4 (15), SC 13D/A (14)1
    All 36 form types

    S-1/A (13), D (11), UPLOAD (10), 8-K/A (8), CORRESP (8), 10-K/A (7), DEF 14A (7), PRE 14A (7), 10-Q/A (6), 10KSB (5), 424B3 (5), S-1 (5), SC 13G (5), 3 (4), EFFECT (4), S-8 (4), DEFA14A (3), SB-2/A (3), SC 13G/A (2), 4/A (1), 424B2 (1), 5 (1), 8-A12G (1), RW (1), S-3 (1), S-8 POS (1), SB-2 (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Aug 30, 2024
    Quarterly report (10-Q) Aug 12, 2025
    Proxy statement (DEF 14A) Jan 19, 2023
    Latest 8-K (8-K) Oct 15, 2024